Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 1999

View Archived Issues

CRCT and Duke receive US BRCA2 gene patent

BioSpecifics announces results of injectable collagenase phase II study

Schering Berlin completes acquisition of Diatide

SmithKline Beecham licenses antigen technology from Cortecs

Nasonex Nasal Spray approved in E.U. for use in young children

Vasogen study shows VasoCare therapy improves blood flow in patients with PVD

Zeria evaluates potential cognition enhancer in healthy volunteers

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Azacycloalkane derivatives from Sanofi-Synthelabo with dual hypoglycemic/antiinflammatory actions

Dopaminergic compounds disclosed by AHP for Parkinson's disease, schizophrenia, etc.

Newly issued patent covers Esteve's novel analgesic agents

Amgen's epoetin alfa approved in children with chronic renal failure

Antiviral agents discovered at U. of Michigan

Alpha2-adrenoceptor ligands from Ortho-McNeil with analgesic and other pharmacological effects

Landmark study in type II diabetics assesses long-term efficacy of Avandia

Potential interaction between S-4661 and valproic acid

Metabolism of S-2150 elucidated in two studies presented at Xenobiotics meeting

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

TKS-159: metabolism of new GI prokinetic agent and comparison with other benzamides

Novartis presents phase I results for transplant drug at ASN

Idun identifies X-ray structure of caspase 8

Novel class of bifunctional anticancer agents discovered at University of Kansas

Visudyne submitted for marketing approval in Canada

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Stabilized 99mTc complex RP-463 for imaging infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...